Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer, Starboard
Pfizer’s stock dips after two former execs say they won’t support Starboard
Pfizer Inc.’s stock dipped 2.5% Thursday after two of its former executives said they would not support an effort by activist shareholder Starboard Value to orchestrate a turnaround. “We have decided not to be involved in the efforts of Starboard Value regarding Pfizer,
Activist Investor Starboard Value Accuses Pfizer Of Pressure Former Execs To Halt Support For Its...
Activist investor Starboard Value accused Pfizer of pressuring its former CEO Ian Read and ex-CFO Frank D’Amelio to halt support for Starboard’s turnaround campaign. Starboard’s Jeff Smith revealed the company allegedly threatened to claw back compensation and cancel unvested shares.
Activist Investor Starboard Value Presses Pfizer's Board Amid Corporate Tensions
The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard pushed Pfizers board to investigate alleged coercive actions. This follows the
2d
on MSN
Why Pfizer Stock Tumbled by Nearly 3% on Thursday
That activist investor is veteran corporate gadfly Starboard Value, which made its letter public just before market open. In ...
4d
What's Happening With Pfizer Stock?
Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...
2d
What's Going On With Pfizer Stock On Thursday?
On Thursday, Starboard Value LP, a significant shareholder of Pfizer Inc. (NYSE:PFE), issued a letter to the company’s Board ...
MarketWatch
2d
Pfizer Inc. stock underperforms Thursday when compared to competitors
Shares of
Pfizer
Inc.
PFE
shed 2.82% to $29.34 Thursday, on what proved to be an all-around grim trading session for the ...
6d
on MSN
Pfizer Stock Rises After It Gets an Activist. What Starboard’s Track Record With Pharma Tells Us.
Starboard has approached two former Pfizer executives, Ian Read and Frank D’Amelio, to assist in its efforts, and they have ...
2d
Pfizer fight with Starboard heats up, hedge fund alleges executive pressure
The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the ...
GEN
12h
StockWatch: Investors Unfazed by Illumina’s MiSeq Product Launches, Starboard’s $1B Stake in Pfizer
Investors shrugged as Illumina pressed its case for building on its longtime leadership in next-generation sequencing, ...
2d
on MSN
Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis
Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...
2d
on MSN
Top Stock Movers Now: Pfizer, First Solar, CVS Health, and More
First Solar ( FSLR) was the worst-performing stock in the S&P 500 when Jefferies lowered its price target, warning that ...
6d
on MSN
Pfizer stock climbs 4% amid reports Starboard has taken $1B stake
Pfizer (PFE) shares were up 4% Monday morning in the wake of reports that activist investor Starboard Value had taken a ...
2d
Pfizer’s Leadership Stability and Activist Investor Watch: A Hold Rating Analysis
Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating on October 7. David ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
starboard
Covid-19
Pharma
albert bourla
Ian Read
Feedback